Gene Therapy Clinical Trials
Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers
The purpose of the study is to identify a surrogate serum marker for tumor hypoxia in patients with lung cancers.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Eligibility
Inclusion Criteria:- Newly diagnosed patients with lung cancer who are undergoing surgical
resection of their tumors Exclusion Criteria:- Patients without non-small cell lung cancer
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Rachel Freiberg
6507254777
Not Recruiting